Xtant Medical Holdings (XTNT)

• Market cap: $67.1M
• 1 day: -3.50%
• 5 days: 1.56%
• 1 month: -19.80%
• 3 months: 19.35%
• 6 months: -14.63%
• Year to date: 3.05%
• 1 year: -56.93%
• 5 years: -57.31%
• 10 years: -98.83%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

About: Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Employees: 215

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

7% more funds holding

Funds holding: 28 [Q3] → 30 (+2) [Q4]

1.25% less ownership

Funds ownership: 70.81% [Q3] → 69.56% (-1.25%) [Q4]

35% less capital invested

Capital invested by funds: $66.1M [Q3] → $42.8M (-$23.3M) [Q4]

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8